Brugada syndrome disease and how to treating

Description:
Brugada syndrome is a genetic disease characterized by an increased risk of sudden death. The syndrome is named by Pedro and Joseph Brugada cardiologist from Spain in 1992. The disease is most likely to cause sudden death during sleep (KMST) or a sudden and Unexpected nocturnal young men in Southeast Asian region.

The cause of death in Brugada syndrome is ventricular fibrillation (a condition in which there is uncoordinated contraction of heart muscle from the ventricle in the heart). In this case ventricular muscle twitches randomly and without coordination so that the ventricle fails to pump blood into the arteries and into systemic circulation.

In many cases that occurred in Southeast Asia, this syndrome more attacking men with an average age of 30-50 years. In Indonesia, this deadly syndrome was first reported by Dr. Muhammad Munawar SpJP year 2002, published in Journal of Cardiology Indonesia.

Symptoms:
The syndrome is almost without symptoms, the patient suddenly died instantly despite previously healthy even no risk factors for coronary heart disease.

Treatment:
Although there is no appropriate treatment that can be trusted and really prevent this syndrome. Efforts that can be performed in patients with Brugada syndrome is the installation of cardioverter-defibrillator devices. Installation that does not mean much if the symptoms go undetected.